Lactin-V

Latest three-month snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.

Vaginal Probiotics · 1 wave · n=36 answers, pooled

By model

How often each model brings the brand up in recommendation answers.

Share of recommendations over time

Wave-by-wave share of recommendation answers that named this brand.

What they call it

Recurring descriptions in the models' own words, grouped by theme.

• investigational product ×35

  “**Lactin-V:** This is **not** a commercially available product. Lactin-V is classified as an investigational **Live Biotherapeutic Product (LBP)**... Because it is an investigational drug that has not yet received FDA approval, it cannot be legally purchased or prescribed outside”

• not commercially available ×14

  “**Lactin-V:** This is **not** a commercially available product. Lactin-V is classified as an investigational **Live Biotherapeutic Product (LBP)**... Because it is an investigational drug that has not yet received FDA approval, it cannot be legally purchased or prescribed outside”

• strong backing from multiple randomized, double-blind, place ×6

  “Lactin‑V has stronger clinical-trial evidence for reducing *recurrent bacterial vaginosis after antibiotic treatment*, but it remains a clinical-trial live biotherapeutic rather than a normal retail product you can reliably buy.”

• generally safe ×4

  “It was generally well tolerated, but that is one mid-stage trial, not the same as definitive approval-grade evidence.”

• not fda-approved for weight loss alone ×4

  “Not because it has stronger clinical evidence—**Lactin‑V does** for preventing recurrent BV after antibiotic treatment—but Lactin‑V is still investigational and **not commercially available or FDA-approved**, so it is not actually something you can buy.”

• not fda-cleared ×4

  “Lactin‑V has stronger clinical-trial evidence *for preventing recurrent BV after prescribed metronidazole*, but it is **not FDA-cleared or commercially available** in the U.”

• not yet fda-approved ×3

  “It is not yet FDA-approved or sold in stores or online.”

• prescription-grade ×3

  “**Lactin-V** is a prescription-grade "Live Biotherapeutic Product" (LBP) currently in clinical development.”

• strong clinical evidence ×3

  “Not because it has stronger clinical evidence—**Lactin‑V does** for preventing recurrent BV after antibiotic treatment—but Lactin‑V is still investigational and **not commercially available or FDA-approved**, so it is not actually something you can buy.”

• vaginal microbiome support ×3

  “** Lactin‑V is a vaginal live biotherapeutic containing a specific *Lactobacillus crispatus* strain, designed to help restore protective vaginal bacteria.”

In their words

66 exact quoted mentions in this snapshot, grouped by coded tone. Recent quotes are deduplicated and mixed across models.

What they recommend

“Based on the evidence, I'd pick **Lactin-V**.”

“If you can only pick one, go with **Lactin-V**.”

“Based on the latest clinical data, **Lactin-V is highly promising and would likely be "worth it" for many women—but it is not yet commercially available or FDA-approved.**”

“The most promising studied vaginal product for reducing recurrent BV was **Lactin-V** (a specific *Lactobacillus crispatus* strain)”

“It has substantially stronger clinical evidence for reducing recurrent bacterial vaginosis after standard antibiotic treatment than Lemme Purr's oral supplement formula.”

Where they hedge

“Lactin‑V has stronger trial evidence for preventing recurrent bacterial vaginosis *after metronidazole*, but it is still investigational—not FDA-cleared or commercially available to buy in the U.S.”

“over 900 women have participated in clinical studies assessing LACTIN-V, with results demonstrating an excellent safety profile and sustainable vaginal colonization of the CTV-05 strain. It's showing promising results for preventing recurre”

“Scientifically, it is highly promising and likely "worth it" for preventing recurrent vaginal infections—but you cannot buy it yet, as it is still in clinical trials and has not been approved by the FDA.”

“Lactin‑V itself is not commercially available or FDA-cleared in the U.S., so there isn't really a cheaper retail equivalent of the exact product.”

“Lactin-V is a prescription-grade "Live Biotherapeutic Product" (LBP) currently in clinical development.”

What they warn about

“**Lactin-V has not yet received FDA approval and is not commercially available for purchase**”

“it is still an investigational product undergoing clinical trials and **cannot legally be sold or prescribed to the general public**.”

“**Lactin‑V isn't currently FDA-cleared or commercially available in the U.S.**”

“**Lactin‑V isn't currently an FDA-cleared, commercially available product in the U.S.**”

“Lactin-V isn't actually for sale. It's an investigational biologic product (Lactobacillus crispatus CTV-05) still moving through clinical trials.”

The substitution map

Which competitors models suggest when shoppers ask for something cheaper.

Where this comes from

16 of 66 mentions appear alongside an identifiable web citation. Citation does not establish causation.

Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.